Is isoproterenol really required during electrophysiological study in patients with Wolff-Parkinson-White syndrome? - Archive ouverte HAL Access content directly
Journal Articles Journal of Electrocardiology Year : 2013

Is isoproterenol really required during electrophysiological study in patients with Wolff-Parkinson-White syndrome?

(1) , (1) , (1, 2) , (1, 2) , (1)
1
2

Abstract

We have studied the results of electrophysiological study (EPS) in patients with Wolff-Parkinson-White syndrome (WPW) and spontaneous adverse clinical presentation and determined whether isoproterenol added incremental value. METHODS: EPS was performed in 63 patients with WPW and adverse clinical presentation at baseline. EPS was repeated after infusion of isoproterenol in 37 patients, including 25 without criteria for a malignant form at baseline. RESULTS: Atrioventricular orthodromic tachycardia was induced 44%, antidromic tachycardia in 11%, atrial fibrillation (AF) in 68% at baseline. At baseline EPS, criteria for a malignant form (AF induction and shortest CL <250 ms) were noted in 60%; tachycardia was not inducible in 16%. All the patients met the criteria for a malignant form after isoproterenol. CONCLUSIONS: EPS at baseline missed 16% of patients at risk of life-threatening arrhythmias who had no inducible tachyarrhythmia and 40% without classical criteria for malignant form.
Not file

Dates and versions

hal-01718098 , version 1 (27-02-2018)

Identifiers

Cite

Maheshwar Pauriah, Gabriel Cismaru, Jean-Marc Sellal, Christian De Chillou, Béatrice Brembilla-Perrot. Is isoproterenol really required during electrophysiological study in patients with Wolff-Parkinson-White syndrome?. Journal of Electrocardiology, 2013, 46 (6), pp.686 - 692. ⟨10.1016/j.jelectrocard.2012.12.019⟩. ⟨hal-01718098⟩
41 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More